Institute of Medicine (U.S.). Board on Population Health and Public Health Practice, Institute of Medicine (U.S.). Committee on the Public Health Effectiveness of the FDA 510(k) Clearance Process, ebrary, Inc, & Wizemann, T. M. (2011). Public health effectiveness of the FDA 510(k) clearance process: Balancing patient safety and innovation : workshop report. National Academies Press.
Успешно скопировано в буфер обмена
Ошибка копирования в буфер обмена
Цитирование в стиле Чикаго (17-е изд.)
Institute of Medicine (U.S.). Board on Population Health and Public Health Practice, Institute of Medicine (U.S.). Committee on the Public Health Effectiveness of the FDA 510(k) Clearance Process, Inc ebrary, и Theresa M. Wizemann. Public Health Effectiveness of the FDA 510(k) Clearance Process: Balancing Patient Safety and Innovation : Workshop Report. Washington, D.C.: National Academies Press, 2011.
Успешно скопировано в буфер обмена
Ошибка копирования в буфер обмена
Цитирование MLA (9-е изд.)
Institute of Medicine (U.S.). Board on Population Health and Public Health Practice, et al. Public Health Effectiveness of the FDA 510(k) Clearance Process: Balancing Patient Safety and Innovation : Workshop Report. National Academies Press, 2011.
Успешно скопировано в буфер обмена
Ошибка копирования в буфер обмена
Предупреждение: эти цитированмия не могут быть всегда правильны на 100%.